Emergence of KPC-134, a KPC-2 variant associated with ceftazidime-avibactam resistance in a ST11 Klebsiella pneumoniae clinical strain

The emergence of various new Klebsiella pneumoniae carbapenemase (KPC) variants leading to ceftazidime-avibactam treatment failure is a new challenge in current clinical anti-infection treatment. Here, we report a ceftazidime-avibactam-resistant K. pneumoniae 1072–2 clinical strain carrying a novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xiangning, Shen, Siquan, Chang, Fan, Liu, Xin, Yue, Jinxi, Xie, Ning, Yin, Lin, Hu, Fupin, Xiao, Daiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Observation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580995/
https://www.ncbi.nlm.nih.gov/pubmed/37772834
http://dx.doi.org/10.1128/spectrum.00725-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580995/
https://www.ncbi.nlm.nih.gov/pubmed/37772834
http://dx.doi.org/10.1128/spectrum.00725-23

Ejemplares similares